FDA approves alternative mammography quality assurance program

An alternative digital full-field mammography quality assurance program has been cleared for use nationwide, according to an announcement from the FDA. The approval paves the way for the method to be deployed in U.S. healthcare facilities in place of device-specific program from manufacturers.

This new alternative standard, based on the American College of Radiology Digital Mammography Quality Control Manual, was found to meet the requirement of being “at least as effective in assuring quality mammography” as following the manufacturers’ quality control manuals.

The alternative method has been approved for use in all healthcare facilities with the requisite imaging systems.

Read the full news release from the FDA here.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.